Ambar Protein [AMBARPIL] vs Nestle India [NESTLEIND] Detailed Stock Comparison
Ambar Protein
BSE
Loading...
Nestle India
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ambar Protein wins in 7 metrics, Nestle India wins in 5 metrics, with 0 ties. Ambar Protein appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ambar Protein | Nestle India | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 73.75 | N/A |
| Price-to-Book Ratio | 4.02 | 57.24 | Ambar Protein |
| Debt-to-Equity Ratio | 74.75 | 29.11 | Nestle India |
| PEG Ratio | N/A | -5.54 | N/A |
| EV/EBITDA | 10.64 | 48.93 | Ambar Protein |
| Profit Margin (TTM) | 1.95% | 15.21% | Nestle India |
| Operating Margin (TTM) | 1.71% | 18.51% | Nestle India |
| EBITDA Margin (TTM) | 1.71% | 18.51% | Nestle India |
| Return on Equity | N/A | 79.99% | N/A |
| Return on Assets (TTM) | N/A | 26.31% | N/A |
| Free Cash Flow (TTM) | N/A | $9.28B | N/A |
| Dividend Yield | N/A | 1.48% | N/A |
| 1-Year Return | 66.81% | -8.04% | Ambar Protein |
| Price-to-Sales Ratio (TTM) | 0.31 | 11.23 | Ambar Protein |
| Enterprise Value | $1.68B | $2,250.45B | Nestle India |
| EV/Revenue Ratio | 0.38 | 11.02 | Ambar Protein |
| Gross Profit Margin (TTM) | N/A | 54.96% | N/A |
| Revenue per Share (TTM) | $776 | $106 | Ambar Protein |
| Earnings per Share (Diluted) | N/A | $16.14 | N/A |
| Beta (Stock Volatility) | -2.16 | 0.24 | Ambar Protein |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambar Protein vs Nestle India Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ambar Protein | -1.99% | -6.87% | -32.52% | 12.44% | 24.14% | 25.12% |
| Nestle India | -1.40% | 1.64% | -4.82% | -1.52% | 4.75% | 7.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ambar Protein | 66.81% | -15.61% | 1,508.77% | 1,508.77% | 1,508.77% | 1,508.77% |
| Nestle India | -8.04% | 19.10% | 44.45% | 280.99% | 659.62% | 120.64% |
Performance & Financial Health Analysis: Ambar Protein vs Nestle India
| Metric | AMBARPIL | NESTLEIND |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.40B | ₹2.30T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 347 | 1,391,893 |
| 90 Day Avg. Volume | 554 | 1,420,157 |
| Last Close | ₹244.05 | ₹1,162.90 |
| 52 Week Range | ₹144.40 - ₹432.85 | ₹1,055.00 - ₹1,389.00 |
| % from 52W High | -43.62% | -16.28% |
| All-Time High | ₹843.50 (Sep 26, 2022) | ₹2,778.00 (Sep 23, 2024) |
| % from All-Time High | -71.07% | -58.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.06% |
| Quarterly Earnings Growth | -0.57% | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.15% |
| Operating Margin (TTM) | 0.02% | 0.19% |
| Return on Equity (TTM) | N/A | 0.80% |
| Debt to Equity (MRQ) | 74.75 | 29.11 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹60.65 | ₹20.80 |
| Cash per Share (MRQ) | ₹2.10 | ₹0.40 |
| Operating Cash Flow (TTM) | ₹0 | ₹34.50B |
| Levered Free Cash Flow (TTM) | ₹0 | ₹32.08B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.48% |
| Last 12-Month Dividend | N/A | ₹35.50 |
Valuation & Enterprise Metrics Analysis: Ambar Protein vs Nestle India
| Metric | AMBARPIL | NESTLEIND |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 73.75 |
| Forward P/E | N/A | 61.76 |
| PEG Ratio | N/A | -5.54 |
| Price to Sales (TTM) | 0.31 | 11.23 |
| Price to Book (MRQ) | 4.02 | 57.24 |
| Market Capitalization | ||
| Market Capitalization | ₹1.40B | ₹2.30T |
| Enterprise Value | ₹1.68B | ₹2.25T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.38 | 11.02 |
| Enterprise to EBITDA | 10.64 | 48.93 |
| Risk & Other Metrics | ||
| Beta | -2.16 | 0.24 |
| Book Value per Share (MRQ) | ₹60.65 | ₹20.80 |
Financial Statements Comparison: Ambar Protein vs Nestle India
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMBARPIL | NESTLEIND |
|---|---|---|
| Revenue/Sales | N/A | ₹50.74B |
| Cost of Goods Sold | N/A | ₹22.85B |
| Gross Profit | N/A | ₹27.89B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹9.43B |
| EBITDA | N/A | ₹10.92B |
| Pre-Tax Income | N/A | ₹8.88B |
| Income Tax | N/A | ₹2.41B |
| Net Income (Profit) | N/A | ₹6.47B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMBARPIL | NESTLEIND |
|---|---|---|
| Cash & Equivalents | N/A | ₹497.80M |
| Total Current Assets | N/A | ₹37.34B |
| Total Current Liabilities | N/A | ₹46.85B |
| Long-Term Debt | N/A | ₹3.64B |
| Total Shareholders Equity | N/A | ₹40.10B |
| Retained Earnings | N/A | ₹39.02B |
| Property, Plant & Equipment | N/A | ₹692.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMBARPIL | NESTLEIND |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMBARPIL | NESTLEIND |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 347 | 1,391,893 |
| Average Daily Volume (90 Day) | 554 | 1,420,157 |
| Shares Outstanding | 5.75M | 964.16M |
| Float Shares | 953,370 | 702.47M |
| % Held by Insiders | 0.79% | 0.63% |
| % Held by Institutions | 0.00% | 0.16% |
Dividend Analysis & Yield Comparison: Ambar Protein vs Nestle India
| Metric | AMBARPIL | NESTLEIND |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹35.50 |
| Last 12-Month Dividend Yield | N/A | 1.48% |
| 3-Year Avg Annual Dividend | N/A | ₹15.37 |
| 3-Year Avg Dividend Yield | N/A | 0.28% |
| 3-Year Total Dividends | N/A | ₹46.12 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |